DOI: 10.1055/s-00000069

Seminars in Liver Disease

Referenz

Huynh H, Ngo VC, Fargnoli J , et al.
Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma.

Clin Cancer Res 2008;
14 (19) 6146-6153

Bibliographische Angaben herunterladen

Suchen in:
Aufrufen in: